Onco-Inmunología Aplicada y Traslacional
O-I Traslacional
Ignacio
Gil Bazo
Investigador hasta 2022
Publicaciones en las que colabora con Ignacio Gil Bazo (12)
2020
-
Are Immune Checkpoint Inhibitors Effective Against Uncommon Oncogene-Driven NSCLC Subtypes?
Journal of Thoracic Oncology
-
PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical Practice
Clinical Cancer Research, Vol. 26, Núm. 16, pp. 4186-4197
-
Performance comparison of two next-generation sequencing panels to detect actionable mutations in cell-free DNA in cancer patients
Clinical Chemistry and Laboratory Medicine, Vol. 58, Núm. 8, pp. 1341-1348
-
Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade
Nature cancer, Vol. 1, Núm. 1, pp. 75-85
2019
2018
-
Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients
Annals of Oncology, Vol. 29, Núm. 5, pp. 1312-1319
-
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer
Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483
-
Targeted DNA sequencing for assessing clonality in multiple lung tumors: A new approach to an old dilemma
Lung Cancer, Vol. 122, pp. 120-123
2016
-
Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value
Tumor Biology, Vol. 37, Núm. 10, pp. 13687-13694
2012
-
The multimodal management of locally advanced N2 non-small cell lung cancer: Is there a role for surgical resection? A single institution's experience
Clinical and Translational Oncology, Vol. 14, Núm. 11, pp. 835-841
2009
-
Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array
British Journal of Cancer, Vol. 101, Núm. 11, pp. 1876-1883
2002
-
Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancer
British Journal of Cancer, Vol. 87, Núm. 2, pp. 158-160